Parmax Pharma Ltd

NSE: PARMAX · BSE: 540359 · Pharmaceuticals & Biotechnology · 6 announcements

Share price: ₹136.40
Market cap: ₹51.03 Cr
Revenue (annual): ₹12.11 Cr
Net profit (annual): ₹-4.16 Cr
P/E (TTM): -42.7×Sector 50.4×
Promoter holding: 64.66%+33.86% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Capital Structure Change 2 Other Announcement 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

2 Sep 2026 21:33 IST BSE

Capital Structure Change

Parmax Pharma Capital Structure Change

Parmax Pharma's promoters acquired shares via preferential allotment. This filing discloses the acquisition of equity stakes by eleven promoter-related entities.

Value: ₹8.32 Cr

Read the filing ↗

2 Sep 2026 10:47 IST BSE

Capital Structure Change

Parmax Pharma Capital Structure Change

Promoter group members Dhiren Shah and Sunil Shah acquired 22,80,444 equity shares in Parmax Pharma Ltd. The acquisition occurred via a preferential allotment on August 29, 2026.

Read the filing ↗